Epigenetic reprogramming induced by key metabolite depletion is an evolutionarily ancient path to tumorigenesis
Disease Models & Mechanisms · 2025
DOI: 10.1242/dmm.052313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2025. Verfasst von Zhe Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong 999077, China. Hauptthemen laut MEDLINE: Carcinogenesis, Epigenesis, Genetic, Drosophila melanogaster, Cellular Reprogramming. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Committee, Science, Technology and Innovation Commission of Shenzhen Municipality, Hong Kong University of Science and Technology.
Abstract (Originalsprache)
Tumor growth is a challenge for multicellular life forms. Contrary to human tumors, which take years to form, tumors in short-living species can arise within days without accumulating multiple mutations, raising the question whether the paths to tumorigenesis in diverse species have any commonalities. In a fly tumor model caused by loss of cell polarity genes, we identified two key metabolic changes: first, systemic depletion of acetyl-CoA leading to a reduction in histone acetylation levels and stochastic silencing of actively transcribed genes; and second, defects in the methionine cycle causing systemic depletion of S-adenosyl methionine, which further reduces histone methylation levels and causes stochastic activation of transposons. Perturbation of the methionine metabolic process inhibits tumor growth. To understand the evolutionary origin of tumorigenesis, we performed comparative studies of fly and human tumors and found that human tumors with metabolic signatures similar to those of fly tumors have a lower mutational load, younger patient age and lower DNA methylation levels. This study indicates that depletion of key metabolites is an evolutionarily ancient driving force for tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong 999077, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
- School of Life Science, Peking University, Beijing 100871, China.
- Department of Chemical and Biological Engineering, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong 999077, China.
- SIAT-HKUST Joint Laboratory of Cell Evolution and Digital Health, HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Futian, Shenzhen 518045, China.
- Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, China.
ORCID-Profile: Jiguang Wang, Yan Yan
Förderung
- University Grants Committee
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Hong Kong University of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Chen, Z., Zhang, X., Deng, M., Li, C., Nguyen, T. T., Liu, M., Dou, K., Ishibashi, T., Wang, J., & Yan, Y. (2025). Epigenetic reprogramming induced by key metabolite depletion is an evolutionarily ancient path to tumorigenesis. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052313
Vancouver
Chen Z, Zhang X, Deng M, Li C, Nguyen TT, Liu M, et al. Epigenetic reprogramming induced by key metabolite depletion is an evolutionarily ancient path to tumorigenesis. Disease Models & Mechanisms. 2025. doi:10.1242/dmm.052313
BibTeX
@article{Chen2025,
author = {Chen, Zhe and Zhang, Xiaomeng and Deng, Mingxi and Li, Chongyang and Nguyen, Thi Thuy and Liu, Min and Dou, Kun and Ishibashi, Toyotaka and Wang, Jiguang and Yan, Yan},
title = {Epigenetic reprogramming induced by key metabolite depletion is an evolutionarily ancient path to tumorigenesis},
journal = {Disease Models & Mechanisms},
year = {2025},
doi = {10.1242/dmm.052313}
}
EUVIMED